Core Laboratories Inc. (NYSE:CLB) Short Interest Down 5.1% in November

Core Laboratories Inc. (NYSE:CLB - Get Free Report) was the target of a large decline in short interest in November. As of November 30th, there was short interest totalling 6,500,000 shares, a decline of 5.1% from the November 15th total of 6,850,000 shares. Based on an average daily volume of 309,300 shares, the days-to-cover ratio is presently 21.0 days. Approximately 14.0% of the company's stock are sold short.

Core Laboratories Stock Up 0.9 %

Shares of Core Laboratories stock traded up $0.18 on Tuesday, reaching $19.14. The stock had a trading volume of 346,121 shares, compared to its average volume of 410,409. The company has a quick ratio of 1.79, a current ratio of 2.48 and a debt-to-equity ratio of 0.55. The stock has a market capitalization of $898.62 million, a P/E ratio of 29.17, a P/E/G ratio of 1.36 and a beta of 2.35. The company has a 50 day moving average price of $19.67 and a 200 day moving average price of $19.70. Core Laboratories has a 1 year low of $13.82 and a 1 year high of $25.13.

Core Laboratories (NYSE:CLB - Get Free Report) last released its quarterly earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.21 by $0.04. Core Laboratories had a net margin of 5.83% and a return on equity of 15.84%. The business had revenue of $134.40 million for the quarter, compared to analyst estimates of $134.16 million. During the same period in the previous year, the company earned $0.22 earnings per share. The business's revenue for the quarter was up 7.2% on a year-over-year basis. As a group, equities research analysts forecast that Core Laboratories will post 0.8 EPS for the current year.

Core Laboratories Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, November 25th. Investors of record on Monday, November 4th were given a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a yield of 0.21%. The ex-dividend date of this dividend was Monday, November 4th. Core Laboratories's dividend payout ratio is currently 6.15%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the stock. Citigroup dropped their price objective on shares of Core Laboratories from $15.00 to $14.00 and set a "sell" rating on the stock in a research note on Thursday, October 31st. StockNews.com upgraded Core Laboratories from a "sell" rating to a "hold" rating in a report on Thursday, November 7th. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company. Based on data from MarketBeat, Core Laboratories currently has an average rating of "Hold" and a consensus price target of $17.00.

Institutional Investors Weigh In On Core Laboratories

Several institutional investors have recently added to or reduced their stakes in CLB. Tidal Investments LLC increased its holdings in shares of Core Laboratories by 1.7% during the third quarter. Tidal Investments LLC now owns 43,862 shares of the oil and gas company's stock valued at $813,000 after acquiring an additional 716 shares in the last quarter. Barclays PLC increased its stake in Core Laboratories by 288.2% during the 3rd quarter. Barclays PLC now owns 83,570 shares of the oil and gas company's stock valued at $1,549,000 after purchasing an additional 62,042 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of Core Laboratories by 0.7% in the third quarter. Geode Capital Management LLC now owns 1,053,204 shares of the oil and gas company's stock worth $19,521,000 after buying an additional 7,721 shares during the last quarter. Disciplined Growth Investors Inc. MN lifted its stake in shares of Core Laboratories by 26.7% during the third quarter. Disciplined Growth Investors Inc. MN now owns 5,653,591 shares of the oil and gas company's stock worth $104,761,000 after buying an additional 1,192,871 shares during the period. Finally, Jane Street Group LLC grew its holdings in shares of Core Laboratories by 53.8% during the third quarter. Jane Street Group LLC now owns 71,989 shares of the oil and gas company's stock valued at $1,334,000 after buying an additional 25,189 shares during the last quarter. Institutional investors and hedge funds own 97.81% of the company's stock.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.